Vaxgen, Inc.

Brisbane, CA 94005

SBIR Award Summary

Total Number of Awards 7
Total Value of Awards $3.66MM
First Award Date 09/29/00
Most Recent Award Date 07/15/04

Key Personnel

Last Name Name Awards Contact
Sinangil Faruk M Sinangil 4
Berman Phillip Berman 3

7 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/15/04 - 06/30/05

DESCRIPTION (provided by applicant): Measuring the effects of an antibody response in vitro in the hopes of deciphering a correlate of protection from infection has been hampered by technical issues and limited access to a suitable set of vaccine trial clinical samples. With the conclusion of VaxGen's Phase III HIV vaccine efficacy trial in 200...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/04 - 02/28/06

DESCRIPTION (provided by applicant): An effective vaccine is the only practical way to halt the AIDS epidemic. The greatest challenge in developing an effective HIV vaccine is antigenic variation. Therefore, the present project aim is to enhance the understanding of antigenic variation by characterizing intra-subtype sequence variation among g...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/03 - 05/31/04

DESCRIPTION (provided by applicant): An effective vaccine is the only practical way to halt the AIDS epidemic. The greatest challenge in developing an effective HIV vaccine is antigenic variation. Therefore, the present project aim is to enhance the understanding of antigenic variation by characterizing intra-subtype sequence variation among g...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/15/02 - 02/28/03

DESCRIPTION (provided by applicant): An effective vaccine is the only practical way to halt the AIDS epidemic. The greatest challenge in developing an effective HIV vaccine is antigenic variation. Therefore, the present project aim is to enhance the understanding of antigenic variation by characterizing intra-subtype sequence variation among g...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/02 - 08/31/04

Given the enormous number of HIV-infected people worldwide, most epidemiologists agree that a vaccine is the only practical solution to stemming the AIDS epidemic. Although a number of different strategies could be utilized, no strategy has yet been proven to elicit a better immune response than one based on the envelope glycoprotein, gp120. The...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/01 - 08/31/02

Given the enormous number of HIV-infected people worldwide, most epidemiologists agree that a vaccine is the only practical solution to stemming the AIDS epidemic. Although a number of different strategies could be utilized, no strategy has yet been proven to elicit a better immune response than one based on the envelope glycoprotein, gp120. The...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/29/00 - 03/28/01

Given the enormous number of HIV-infected people worldwide, most epidemiologists agree that a vaccine is the only practical solution to stemming the AIDS epidemic. Although a number of different strategies could be utilized, no strategy has yet been proven to elicit a better immune response than one based on the envelope glycoprotein, gp120. The...